FDA OKs Return of Once-Withdrawn Leukemia Drug

12:00 EDT 1 Sep 2017 | MedlinePlus

At lower dose, Mylotarg extended survival against a certain type of blood cancer

HealthDay news image

Source: HealthDay
Related MedlinePlus Pages: Acute Myeloid Leukemia, Medicines

Original Article: FDA OKs Return of Once-Withdrawn Leukemia Drug


More From BioPortfolio on "FDA OKs Return of Once-Withdrawn Leukemia Drug"

Quick Search

Relevant Topics

Monoclonal antibodies MAbs
Monoclonal antibodies recognise and attach to specific proteins produced by cells.  Types of monoclonal antibodies used to treat cancer cells: Block cell dividing dividing signals Transport cancer drugs or radiation to cancer cells Tr...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...